PHARM: But I Don’t Have Diabetes – SGLT2 in Heart Failure Management

Select a ModuleModule DetailsReview MaterialsEvaluate ModulePrint Certificate


Robert Page, PharmD

Learning Outcomes:

  • Describe the epidemiology and pathophysiological connection between heart failure and diabetes.
  • Highlight the mechanism of action, pharmacokinetics, side effects, contraindications, and monitoring parameters for the SGLT2 approved for the use in heart failure.
  • Using evidenced based data, discuss the role that SGLT2 medications have in the management of patients with heart failure.

This activity is approved for 0.75 contact hour(s) of continuing education by the American Association of Nurse Practitioners®. Activity ID# 22055477. This activity was planned in accordance with AANP Accreditation Standards and Policies.